Reaktivation

Reactivation, also known as reactivation therapy, is a medical procedure used to treat certain conditions, primarily in the field of oncology. It involves the use of a patient's own immune system to fight cancer cells, typically after initial treatment has been completed. The process begins with the collection of immune cells from the patient, which are then activated and expanded in a laboratory. These activated cells are then infused back into the patient, where they are hoped to recognize and destroy any remaining cancer cells.

Reactivation therapy is most commonly used in the treatment of melanoma, a type of skin cancer, and certain types of lymphoma. It has also been explored for use in other cancers, such as breast cancer and prostate cancer, but its effectiveness in these areas is less established. The procedure is generally well-tolerated, with common side effects including flu-like symptoms and low-grade fever. Serious side effects are rare but can include infections and allergic reactions.

The effectiveness of reactivation therapy varies depending on the type of cancer and the patient's overall health. It is often used as an adjuvant therapy, meaning it is given after other treatments have been completed to help eliminate any remaining cancer cells. The procedure can be repeated if necessary, with the patient's immune system gradually becoming more effective over time.

Reactivation therapy is a promising area of cancer treatment, offering a personalized approach that utilizes the patient's own immune system. However, it is not a standalone treatment and is typically used in conjunction with other therapies. Ongoing research is focused on improving the procedure and expanding its use to other types of cancer.